Poor response to long-term albendazole therapy of hydatid liver cysts

Scand J Infect Dis. 1989;21(3):323-5. doi: 10.3109/00365548909035703.

Abstract

Seven patients with uncomplicated hepatic hydatid cysts (Echinococcus granulosus) were treated with albendazole 10 mg/kg/day for 2-6 months (mean 4 months). Serial sonographic evaluation showed reduction in cyst size in only 1 patient (the anteroposterior diameter decreased from 16.5 cm to 4.9 cm). Therapy in this patient was discontinued after 4 months due to development of jaundice. Albendazole appears to have a limited role in the treatment of hydatid disease of the liver.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Albendazole
  • Anthelmintics / therapeutic use*
  • Benzimidazoles / adverse effects
  • Benzimidazoles / therapeutic use*
  • Drug Evaluation
  • Echinococcosis, Hepatic / blood
  • Echinococcosis, Hepatic / drug therapy*
  • Echinococcosis, Hepatic / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Liver / pathology
  • Male
  • Middle Aged
  • Ultrasonography

Substances

  • Anthelmintics
  • Benzimidazoles
  • Albendazole